Study Stopped
Deemed not human subjects research
Optimization of Collection Methods for Studies of the Human Microbiota
2 other identifiers
observational
N/A
1 country
1
Brief Summary
Background: The human microbiota is the bacteria and other microbes found in and on the human body. Scientists study the microbiota because it is related to many health conditions. The way samples are collected and handled can greatly affect microbiota study findings. Researchers want to learn more about how collection methods affect these studies. Objectives: To compare different oral and fecal collection methods. To test the effect of new methods to get DNA out of these samples. Eligibility: Adults ages 18 and older who are National Cancer Institute employees and have not taken antibiotics in the past 3 months Design: Participants will discuss the study with researchers. Participants will give an oral or fecal sample or both. For the oral sample, participants will be told what not to do beforehand. This includes chewing gum and smoking. Participants will spit saliva into a tube. Then they will get mouthwash in a vial. They will swish and gargle the mouthwash for 30 seconds then spit it back in the vial. Participants giving a fecal sample will get a collection kit. They can collect the sample at home or elsewhere. Participants will have a bowel movement into the collection container. They will smear some of it on a card with a stick and put the rest in 2 tubes. They will mix the feces with the solution in the tubes. Participants will write the date and time of collection on the instructions and return the sample within 24 hours. Participants providing both samples could have 3 study visits: 1 to give an oral sample, 1 to get the fecal sample collection kit, and 1 to return that sample.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Nov 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2018
CompletedFirst Submitted
Initial submission to the registry
November 3, 2018
CompletedFirst Posted
Study publicly available on registry
November 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 27, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 27, 2020
CompletedOctober 28, 2020
October 1, 2020
2 years
November 3, 2018
October 27, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oral and/or fecal microbiota
relative abundance and phylogenetic diversity of their oral and/or fecal microbiota
1 month
Study Arms (1)
General Individuals
Any adult working at the NCI who has not used antibiotics in the past 3 months.
Eligibility Criteria
We plan to recruit 100 adults who work at the NCI, either in Shady Grove or in the Advanced Technology Center (ATC), who are willing to provide oral and/or fecal samples. We will include any participant that is at least 18 years of age or older who is employed at NCI and has not taken antibiotics anytime in the past 3 months since antibiotic use has been shown to disrupt the microbiota.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
NIH NCI Shady Grove
Rockville, Maryland, 20850, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Emily J Vogtmann, Ph.D.
National Cancer Institute (NCI)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- NIH
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 3, 2018
First Posted
November 6, 2018
Study Start
November 1, 2018
Primary Completion
October 27, 2020
Study Completion
October 27, 2020
Last Updated
October 28, 2020
Record last verified: 2020-10